Graham Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
38,159
+20,606
| +117% | +$75K | ﹤0.01% | 1139 |
|
|
2025
Q1 | $33.7K | Buy |
+17,553
| New | +$33.7K | ﹤0.01% | 1209 |
|
|
2024
Q3 | – | Sell |
-57,624
| Closed | -$58.8K | – | 1041 |
|
|
2024
Q2 | $58.8K | Buy |
57,624
+28,838
| +100% | +$29.4K | ﹤0.01% | 955 |
|
|
2024
Q1 | $52.7K | Buy |
28,786
+5,153
| +22% | +$9.43K | ﹤0.01% | 986 |
|
|
2023
Q4 | $29.3K | Buy |
+23,633
| New | +$29.3K | ﹤0.01% | 925 |
|
|
2023
Q3 | – | Sell |
-26,586
| Closed | -$24.3K | – | 979 |
|
|
2023
Q2 | $24.3K | Buy |
+26,586
| New | +$24.3K | ﹤0.01% | 917 |
|